{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:27:18Z","timestamp":1707524838633},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,19]]},"DOI":"10.7759\/cureus.33965","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T14:46:35Z","timestamp":1674139595000},"source":"Crossref","is-referenced-by-count":0,"title":["Pleural Mesothelioma: A Rapid Evolution of an Indolent Disease"],"prefix":"10.7759","author":[{"given":"Miguel","family":"Romano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Afonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-016-1080-z","article-title":"Management of malignant pleural mesothelioma\u00a0- part\u00a01: epidemiology, diagnosis, and staging: Consensus of the Austrian Mesothelioma Interest Group (AMIG)","volume":"128","author":"Geltner C","year":"2016","unstructured":"Geltner C, Errhalt P, Baumgartner B, et al.. Management of malignant pleural mesothelioma\u00a0- part\u00a01: epidemiology, diagnosis, and staging: Consensus of the Austrian Mesothelioma Interest Group (AMIG). Wien Klin Wochenschr. 2016, 128:611-7. 10.1007\/s00508-016-1080-z","journal-title":"Wien Klin Wochenschr"},{"key":"ref2","article-title":"Mesothelioma: A Review","volume":"12","author":"Mott FE","year":"2012","unstructured":"Mott FE. Mesothelioma: A Review. Ochsner J. 2012, 12:70-9.","journal-title":"Ochsner J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0b013e3282f0c0a2","article-title":"US mesothelioma patterns 1973-2002: indicators of change and insights into background rates","volume":"17","author":"Teta MJ","year":"2008","unstructured":"Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED. US mesothelioma patterns 1973-2002: indicators of change and insights into background rates. Eur J Cancer Prev. 2008, 17:525-34. 10.1097\/CEJ.0b013e3282f0c0a2","journal-title":"Eur J Cancer Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.10.4117","article-title":"ERCC1 as a biological marker guiding management in malignant pleural mesothelioma","volume":"15","author":"Cihan YB","year":"2014","unstructured":"Cihan YB, Ozturk A, Arslan A, Deniz K, Baran M, Karaca H. ERCC1 as a biological marker guiding management in malignant pleural mesothelioma. Asian Pac J Cancer Prev. 2014, 15:4117-23. 10.7314\/apjcp.2014.15.10.4117","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009093","article-title":"Analysis of current trends in United States mesothelioma incidence","volume":"145","author":"Price B","year":"1997","unstructured":"Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 1997, 145:211-8. 10.1093\/oxfordjournals.aje.a009093","journal-title":"Am J Epidemiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1179\/oeh.2007.13.4.398","article-title":"Incidence and descriptive epidemiology of mesothelioma in the United States, 1999-2002","volume":"13","author":"Larson T","year":"2007","unstructured":"Larson T, Melnikova N, Davis SI, Jamison P. Incidence and descriptive epidemiology of mesothelioma in the United States, 1999-2002. Int J Occup Environ Health. 2007, 13:398-403. 10.1179\/oeh.2007.13.4.398","journal-title":"Int J Occup Environ Health"},{"key":"ref7","unstructured":"Surveillance, Epidemiology, and End Results Cancer Statistics Review\u2014Mesothelioma fast stats. (2023). Accessed. January 19, 2023: http:\/\/seer.cancer.gov\/faststats\/selections.php."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2014.03.030","article-title":"Preventing pleural mesothelioma in patients with recognizable asbestos-related pleural plaques","volume":"148","author":"Acton V","year":"2014","unstructured":"Acton V. Preventing pleural mesothelioma in patients with recognizable asbestos-related pleural plaques. J Thorac Cardiovasc Surg. 2014, 148:1763. 10.1016\/j.jtcvs.2014.03.030","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-2-11","article-title":"Multimodal treatment for resectable epithelial type malignant pleural mesothelioma","volume":"2","author":"Yoshino I","year":"2004","unstructured":"Yoshino I, Yamaguchi M, Okamoto T, Ushijima C, Fukuyama Y, Ichinose Y, Maehara Y. Multimodal treatment for resectable epithelial type malignant pleural mesothelioma. World J Surg Oncol. 2004, 2:11. 10.1186\/1477-7819-2-11","journal-title":"World J Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2305-5839.2015.07.03","article-title":"Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma","volume":"3","author":"Zhang W","year":"2015","unstructured":"Zhang W, Wu X, Wu L, Zhang W, Zhao X. Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma. Ann Transl Med. 2015, 3:182. 10.3978\/j.issn.2305-5839.2015.07.03","journal-title":"Ann Transl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-709","article-title":"Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions","volume":"14","author":"Szulkin A","year":"2014","unstructured":"Szulkin A, Otv\u00f6s R, Hillerdal CO, et al.. Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions. BMC Cancer. 2014, 14:709. 10.1186\/1471-2407-14-709","journal-title":"BMC Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31822a3740","article-title":"Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy","volume":"6","author":"Kao SC","year":"2011","unstructured":"Kao SC, Klebe S, Henderson DW, et al.. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy. J Thorac Oncol. 2011, 6:1923-9. 10.1097\/JTO.0b013e31822a3740","journal-title":"J Thorac Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s002680020021","article-title":"Treatment of malignant mesothelioma","volume":"25","author":"Jaklitsch MT","year":"2001","unstructured":"Jaklitsch MT, Grondin SC, Sugarbaker DJ. Treatment of malignant mesothelioma. World J Surg. 2001, 25:210-7. 10.1007\/s002680020021","journal-title":"World J Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2007.01.011","article-title":"A phase II study of intrapleural immunochemotherapy, pleurectomy\/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma","volume":"31","author":"Rusch VW","year":"2007","unstructured":"Rusch VW. A phase II study of intrapleural immunochemotherapy, pleurectomy\/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2007, 31:534-5. 10.1016\/j.ejcts.2007.01.011","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug LM","year":"2009","unstructured":"Krug LM, Pass HI, Rusch VW, et al.. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009, 27:3007-13. 10.1200\/JCO.2008.20.3943","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0063-2016","article-title":"Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment","volume":"25","author":"Bibby AC","year":"2016","unstructured":"Bibby AC, Tsim S, Kanellakis N, et al.. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev. 2016, 25:472-86. 10.1183\/16000617.0063-2016","journal-title":"Eur Respir Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2017-104298","article-title":"Estimation of the global burden of mesothelioma deaths from incomplete national mortality data","volume":"74","author":"Odgerel CO","year":"2017","unstructured":"Odgerel CO, Takahashi K, Sorahan T, et al.. Estimation of the global burden of mesothelioma deaths from incomplete national mortality data. Occup Environ Med. 2017, 74:851-8. 10.1136\/oemed-2017-104298","journal-title":"Occup Environ Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13665-013-0045-1","article-title":"Prognostic factors for malignant pleural mesothelioma","volume":"2","author":"Brims FJ","year":"2013","unstructured":"Brims FJ, Maskell NA. Prognostic factors for malignant pleural mesothelioma. Curr Respir Care Rep. 2013, 2:100-108. 10.1007\/s13665-013-0045-1","journal-title":"Curr Respir Care Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2013.10.004","article-title":"Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"25","author":"Rosenzweig KE","year":"2013","unstructured":"Rosenzweig KE. Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2013, 25:245-50. 10.1053\/j.semtcvs.2013.10.004","journal-title":"Semin Thorac Cardiovasc Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/131024-pleural-mesothelioma-a-rapid-evolution-of-an-indolent-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:58Z","timestamp":1707508078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/131024-pleural-mesothelioma-a-rapid-evolution-of-an-indolent-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.33965","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,19]]}}}